IAVI

Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

Features

Community-rooted science: a pathway to accelerating vaccine discovery

December 7, 2022

In the wake of cutting-edge science, it is essential to nurture a community-rooted and participant-centered approach to accelerate vaccine research.

Read more

Features

Meet the IAVI scientist on the cusp of developing a novel HIV vaccine candidate

December 5, 2022

Jama Dalel, Ph.D., post-doctoral researcher, IAVI–Human Immunology Laboratory (HIL), Imperial College, London

Read more

Features

Meet the IAVI scientist applying her skills to decipher how local HIV circulating strains are evolving within India and how this landscape affects applicability of prevention products for and by LMICs

November 28, 2022

Jyoti Sutar, Ph.D., senior research associate, Antibody Translational Research Program (previously the HIV Vaccine Translational Research Laboratory)

Read more

Features

Laying the groundwork for success: TB vaccine highlights at the Union

November 21, 2022

We must plan for their introduction and demand what is needed for new TB vaccines to reach End TB targets, experts say.

Read more

Features

Meet the IAVI scientist who leads the team that is the first from an LMIC to report potent monoclonal neutralizing antibodies against SARS-CoV-2

November 17, 2022

Jayanta Bhattacharya, Ph.D., director, Antibody Translational Research Program and principal investigator, Translational Health Science and Technology Institute

Read more

Features

IAVI scientists publish findings that suggest intranasal vaccination can prevent COVID-19 breakthrough infections in small animal models

September 20, 2022

Preclinical results support intranasal delivery of IAVI’s COVID-19 vaccine candidate.

Read more

Features

IAVI launches toolkit to build vaccine literacy knowledge

September 1, 2022

Covering HIV, TB, and Lassa virus vaccines, from basic science and clinical trials to social and ethical issues related to vaccine development and testing, as well as future access.

Read more

Features

Donor Spotlight: Japanese Government

August 29, 2022

IAVI recognizes the government of Japan’s continued commitment to HIV vaccine research and applauds their leadership in the fight against infectious diseases.

Read more